Phio Pharmaceuticals Corp. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PHIO, updated each market day.
PHIO AI Sentiment
AI predicts Phio Pharmaceuticals Corp. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Phio Pharmaceuticals Corp. Common Stock
Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.
Sector
Exchange
Market Cap
$14,521,562
Cap Tier
Employees
6
Headquarters
KING OF PRUSSIA, PA
Listed Since
May 10, 2012
Website
PHIO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PHIO Volatility
Phio Pharmaceuticals Corp. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
